$1.14 -0.04 (-3.45%)

Polyrizon Ltd. Ordinary Shares (PLRZ)

Polyrizon Ltd. is a biotechnology company specializing in the development of advanced antimicrobial and anti-viral solutions. The company focuses on innovative technologies aimed at enhancing hygiene and preventing the spread of infectious diseases. Through its research and development efforts, Polyrizon aims to create effective, safe, and sustainable health products for various applications.

🚫 Polyrizon Ltd. Ordinary Shares does not pay dividends

Company News

US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert
Benzinga • Rishabh Mishra • May 5, 2025

U.S. stock futures fell on Monday after a nine-day winning streak on the S&P 500 index. Investors will keep an eye on the Federal Reserve's decision on interest rates this week. Analysts say any de-escalation in trade tensions should be positive for the economy and financial markets.

Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform
GlobeNewswire Inc. • Polyrizon Ltd. • March 10, 2025

Polyrizon, a biotech company, has initiated preclinical studies for intranasal Naloxone, a treatment for opioid overdose, using its Trap and Target (T&T) platform. The studies aim to assess key parameters like drug loading, release kinetics, and nasal deposition, paving the way for further safety and efficacy testing.